Inventor
AKTOUDIANAKIS EVANGELOS
US17 patents
Patents
17 patentsUS9670205B2Jun 6, 2017
Toll like receptor modulator compounds
GILEAD SCIENCES INC100 citations98
US10285990B2May 14, 2019
Toll like receptor modulator compounds
GILEAD SCIENCES INC11 citations84
US10774071B2Sep 15, 2020
PD-1/PD-L1 inhibitors
GILEAD SCIENCES INC7 citations82
US10710986B2Jul 14, 2020
PD-1/PD-L1 inhibitors
GILEAD SCIENCES INC4 citations82
US9458145B2Oct 4, 2016
Benzimidazole derivatives as bromodomain inhibitors
GILEAD SCIENCES INC12 citations82
US10442804B2Oct 15, 2019
Compounds for the treatment of hepatitis B virus infection
GILEAD SCIENCES INC4 citations73
US9255089B2Feb 9, 2016
Benzimidazolone derivatives as bromodomain inhibitors
GILEAD SCIENCES INC7 citations72
US11453681B2Sep 27, 2022
Substituted eneoxindoles and uses thereof
GILEAD SCIENCES INC2 citations70
US12377100B2Aug 5, 2025
Toll like receptor modulator compounds
GILEAD SCIENCES INC0 citations62
US12338233B2Jun 24, 2025
PD-1/Pd-L1 inhibitors
GILEAD SCIENCES INC0 citations61
US12269812B2Apr 8, 2025
PD-1/PD-L1 inhibitors
GILEAD SCIENCES INC0 citations61
US11555029B2Jan 17, 2023
PD-1/PD-L1 inhibitors
GILEAD SCIENCES INC1 citations61
US12037342B2Jul 16, 2024
Substituted eneoxindoles and uses thereof
GILEAD SCIENCES INC0 citations60
US12590062B2Mar 31, 2026
PD-1/PD-L1 inhibitors
GILEAD SCIENCES INC0 citations50
US10899735B2Jan 26, 2021
PD-1/PD-L1 inhibitors
GILEAD SCIENCES INC0 citations50
US10017501B2Jul 10, 2018
Benzimidazole derivatives as bromodomain inhibitors
GILEAD SCIENCES INC0 citations50
US7998950B2Aug 16, 2011
Antiviral compounds
GILEAD SCIENCES INC1 citations49